Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

2(28.6%)

Phase 3

2(28.6%)

7Total

Phase 4(3)

N/A(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01800747Phase 4Completed

Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)

Role: lead

NCT01803919Not ApplicableTerminated

Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients

Role: collaborator

NCT02608723Phase 4Completed

Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes?

Role: lead

NCT01939925Not ApplicableCompleted

Communicating Evidence From Systematic Reviews to the Public

Role: collaborator

NCT01440725Phase 3Completed

Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma

Role: collaborator

NCT01375790Phase 3Completed

Whole-body Vibration Training in Older People

Role: lead

NCT01116310Phase 4Unknown

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause

Role: collaborator

All 7 trials loaded